Molecular Partners AG (MOLN)
4.306
+0.10
(+2.43%)
USD |
NASDAQ |
Dec 09, 16:00
Molecular Partners EPS Diluted (Quarterly): -0.3955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
| NewCelX Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.79M |
| Total Expenses (Quarterly) | 14.79M |
| Enterprise Value | 31.60M |
| Earnings Yield | -44.34% |
| Normalized Earnings Yield | -42.89 |